Northpointe Capital’s Medtronic MDT Stock Holding History

Northpointe Capital’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-13,376	Closed	-$1.3M	–	94
2019 Q2	$1.3M	Sell	13,376 -9,498	-42%	-$867K	0.41%	79
2019 Q1	$2.08M	Sell	22,874 -6,266	-22%	-$561K	0.66%	71
2018 Q4	$2.65M	Buy	+29,140	New	+$2.72M	0.6%	69
2017 Q3	–	Sell	-32,398	Closed	-$2.88M	–	182
2017 Q2	$2.88M	Buy	32,398 +1,421	+5%	+$120K	0.3%	131
2017 Q1	$2.5M	Buy	+30,977	New	+$2.42M	0.27%	137
2015 Q2	–	Sell	-60,231	Closed	-$4.7M	–	218
2015 Q1	$4.7M	Buy	+60,231	New	+$4.57M	0.51%	64
2014 Q2	–	Sell	-31,000	Closed	-$1.91M	–	253
2014 Q1	$1.91M	Buy	31,000 +3,534	+13%	+$206K	0.19%	116
2013 Q4	$1.58M	Sell	27,466 -650	-2%	-$36.9K	0.14%	146
2013 Q3	$1.5M	Buy	28,116 +11,206	+66%	+$603K	0.18%	132
2013 Q2	$870K	Buy	+16,910	New	+$836K	0.1%	150

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northpointe Capital's MDT Position: Q3 2019 in Review

Northpointe Capital sold out of Medtronic (MDT) in Q3 2019, closing a stake of 13,376 shares — an estimated $1.3M sold.

Northpointe Capital first reported a position in MDT in Q2 2013 and held it in 10 quarters. The position peaked at $4.7M in Q1 2015. 1,645 funds tracked by Wall St. Rank hold MDT as of Q3 2019.

Northpointe Capital reported no remaining Medtronic position as of Q3 2019 after selling out during the quarter.
Northpointe Capital sold 13,376 Medtronic shares in Q3 2019, an estimated $1.3M.
Northpointe Capital first reported a position in Medtronic in Q2 2013 and held it in 10 quarters.
Northpointe Capital's Medtronic position peaked at $4.7M in Q1 2015.
1,645 funds tracked by Wall St. Rank held Medtronic as of Q3 2019.

Based on Northpointe Capital's 13F filing for Q3 2019, filed 16 Oct 2019.